Cedric Hermans: New Chinese Data Expand the Evidence for Hemophilia B Gene Therapy
Cedric Hermans, Head of Haemophilia Centre at the Saint-Luc University Hospital, Brussels, shared a post on LinkedIn about a recent article by Feng Xue et al., published in Nature Medicine, adding:
“Important new gene therapy data from China.
A phase 1/2 and multicentre phase 3 study provides important Chinese clinical data on BBM-H901, an AAV-based FIX-Padua gene therapy for haemophilia B.
The phase 3 trial included 26 Chinese patients, addressing a population in which haemophilia gene-therapy data have so far been relatively limited.
At 52 weeks:
- Mean FIX activity: 41.9 IU/dL
- 80.8% experienced zero bleeds
- 97.9% reduction in bleeding
- 95% reduction in FIX infusions
- No target joints at one year.
Particularly noteworthy is the substantial haemostatic conversion achieved with a vector dose of only 5 × 10¹² vg/kg.
Beyond the encouraging efficacy results, this study is important because it expands the geographical and ethnic evidence base for haemophilia B gene therapy and demonstrates the emergence of innovative gene-therapy development from China.
Longer follow-up will now be essential to assess durability.”
Title: Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials
Authors: Feng Xue, Mankai Ju, Tienan Zhu, Zeping Zhou, Jing Sun, Linhua Yang, Zhenyu Yan, Hu Zhou, Xin Du, ChangCheng Zheng, Jing Zheng, Xia Wu, Zengmin Du, Wei Jiang, Caifeng Yang, Xiao Xiao, Wei Liu, Renchi Yang, Lei Zhang

Other posts featuring Cedric Hermans on Hemostasis Today.
-
Sep 15, 2026, 15:00Sarah Wachtman: Modeling AAV-Based Gene Therapy for Hemophilia A Using Pediatric Liver Organoids
-
Sep 15, 2026, 15:00Ashenafi Tazebew Amare: From Blood Donation to Innovation and Patient Access
-
Sep 15, 2026, 14:56Glanzmann Thrombasthenia Beyond Platelet Transfusion
-
Sep 15, 2026, 14:55Christina Pohlman: The Hidden Complexity of Warfarin Therapy in APS
-
Sep 15, 2026, 14:44Consuela A. Albright: Building a More Connected Sickle Cell Care System
-
Sep 15, 2026, 14:43Andrew Jackson: Cyanosis as a Clue to Central Venous Obstruction
-
Sep 15, 2026, 14:43Andy Darlington: Randomized Evidence for Catheter-Based Treatment of Intermediate-High-Risk PE
-
Sep 15, 2026, 14:31Yaozhi Wang: AI Increased Incidental Pulmonary Embolism Detection
-
Sep 15, 2026, 14:30Moe Alsumidaie: Mitapivat Challenges the Transfusion-Centric Model of Thalassaemia Care